Daniel H. Robertson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel H. Robertson has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
C. T. White
14 shared publicationsD. W. Brenner
10 shared publications- John W. Mintmire
Department of Physics, Oklahoma State University, Stillwater, Oklahoma 74078
8 shared publications C.T. White
Theoretical Chemistry Section, Naval Research Laboratory, Washington, DC 20375
4 shared publications- Michal Vieth
Eli Lilly and Company, Lilly Research Laboratories, Lilly Corporate Center, DC 1513, Indianapolis, Indiana 46285, USA
4 shared publications - Brett. I. Dunlap
Code 6189, Chemistry Division, Naval Research Laboratory, Washington, DC 20375, USA
3 shared publications
Latest Publications
- Open Access
Text mining and portal development for gene-specific publications on Alzheimer’s disease and other neurodegenerative diseases
Background: Tremendous research efforts have been made in the Alzheimer’s disease (AD) field to understand the disease etiology, progression and discover treatments for AD. Many mechanistic hypotheses, therapeutic targets and treatment strategies have been proposed in the last few decades. Reviewing previous work and staying current on this ever-growing body of AD publications is an essential yet difficult task for AD researchers. Methods: In this study, we designed and implemented a natural language processing (NLP) pipeline to extract gene-specific neurodegenerative disease (ND) -focused information from the PubMed database. The collected publication information was filtered and cleaned to construct AD-related gene-specific publication profiles. Six categories of AD-related information are extracted from the processed publication data: publication trend by year, dementia type occurrence, brain region occurrence, mouse model information, keywords occurrence, and co-occurring genes. A user-friendly web portal is then developed using Django framework to provide gene query functions and data visualizations for the generalized and summarized publication information. Results: By implementing the NLP pipeline, we extracted gene-specific ND-related publication information from the abstracts of the publications in the PubMed database. The results are summarized and visualized through an interactive web query portal. Multiple visualization windows display the ND publication trends, mouse models used, dementia types, involved brain regions, keywords to major AD-related biological processes, and co-occurring genes. Direct links to PubMed sites are provided for all recorded publications on the query result page of the web portal. Conclusion: The resulting portal is a valuable tool and data source for quick querying and displaying AD publications tailored to users’ interested research areas and gene targets, which is especially convenient for users without informatic mining skills. Our study will not only keep AD field researchers updated with the progress of AD research, assist them in conducting preliminary examinations efficiently, but also offers additional support for hypothesis generation and validation which will contribute significantly to the communication, dissimilation and progress of AD research.
Open AccessText mining and portal development for gene-specific publications on Alzheimer’s disease and other neurodegenerative diseases
Background: Tremendous research efforts have been made in the Alzheimer’s disease (AD) field to understand the disease etiology, progression and discover treatments for AD. Many mechanistic hypotheses, therapeutic targets and treatment strategies have been proposed in the last few decades. Reviewing previous work and staying current on this ever-growing body of AD publications is an essential yet difficult task for AD researchers. Methods: In this study, we designed and implemented a natural language processing (NLP) pipeline to extract gene-specific neurodegenerative disease (ND) -focused information from the PubMed database. The collected publication information was filtered and cleaned to construct AD-related gene-specific publication profiles. Six categories of AD-related information are extracted from the processed publication data: publication trend by year, dementia type occurrence, brain region occurrence, mouse model information, keywords occurrence, and co-occurring genes. A user-friendly web portal is then developed using Django framework to provide gene query functions and data visualizations for the generalized and summarized publication information. Results: By implementing the NLP pipeline, we extracted gene-specific ND-related publication information from the abstracts of the publications in the PubMed database. The results are summarized and visualized through an interactive web query portal. Multiple visualization windows display the ND publication trends, mouse models used, dementia types, involved brain regions, keywords to major AD-related biological processes, and co-occurring genes. Direct links to PubMed sites are provided for all recorded publications on the query result page of the web portal. Conclusion: The resulting portal is a valuable tool and data source for quick querying and displaying AD publications tailored to users’ interested research areas and gene targets, which is especially convenient for users without informatic mining skills. Our study will not only keep AD field researchers updated with the progress of AD research, assist them in conducting preliminary examinations efficiently, but also offers additional support for hypothesis generation and validation which will contribute significantly to the communication, dissimilation and progress of AD research.
- Open Access
Utilization of Electronic Health Records for the Assessment of Adiponectin Receptor Autoantibodies during the Progression of Cardio-metabolic Comorbidities
BACKGROUND: Diabetes is a complex, multi-symptomatic disease that drives healthcare costs through its complications as the prevalence of this disease grows rapidly world-wide. Real-world electronic health records (EHRs) coupled with patient biospecimens, biological understanding, and technologies can lead to identification of new diagnostic markers. METHODS: We analyzed the 20-year EHRs of 1862 participants with midpoint samples (10-year) in an observational study of type 2 diabetes and cardiovascular arterial disease (CVAD) conducted by the Fairbanks Institute to test the diagnostic biomarkers. Participants were assigned to four cohorts (healthy, diabetes, CVAD, CVAD+diabetes) based on EHR data analysis. The immunoassay reference range for circulating autoantibodies against the C-terminal fragment of adiponectin receptor 1 (IgG-CTF) was determined and used to predict outcomes post-sample. RESULTS: The IgG-CTF reference range was determined [75–821 ng/mL] and out-of-range values of IgG-CTF values predicted increased likelihood of additional comorbidities and mortality determined from the EHRs 10 years after sample collection. The probability of mortality was lower in patients with elevated IgG-CTF >821 ng/mL [OR 0.49–0.0] and higher in patients with lowered IgG-CTF <75 ng/mL [OR 3.74–9.64]. Although many patients at the time of sample collection had other conditions (hypertension, hyperlipidemia, or elevated uristatin values), only hypertension correlated with increased likelihood of mortality (OR 4.36–5.34). CONCLUSIONS: This study confirms that retrospective analysis of biorepositories coupled with EHRs can provide insight into novel diagnostic markers and the IgG-CTF marker can predict the likelihood of progressing to additional comorbidities or mortality.
Open AccessUtilization of Electronic Health Records for the Assessment of Adiponectin Receptor Autoantibodies during the Progression of Cardio-metabolic Comorbidities
BACKGROUND: Diabetes is a complex, multi-symptomatic disease that drives healthcare costs through its complications as the prevalence of this disease grows rapidly world-wide. Real-world electronic health records (EHRs) coupled with patient biospecimens, biological understanding, and technologies can lead to identification of new diagnostic markers. METHODS: We analyzed the 20-year EHRs of 1862 participants with midpoint samples (10-year) in an observational study of type 2 diabetes and cardiovascular arterial disease (CVAD) conducted by the Fairbanks Institute to test the diagnostic biomarkers. Participants were assigned to four cohorts (healthy, diabetes, CVAD, CVAD+diabetes) based on EHR data analysis. The immunoassay reference range for circulating autoantibodies against the C-terminal fragment of adiponectin receptor 1 (IgG-CTF) was determined and used to predict outcomes post-sample. RESULTS: The IgG-CTF reference range was determined [75–821 ng/mL] and out-of-range values of IgG-CTF values predicted increased likelihood of additional comorbidities and mortality determined from the EHRs 10 years after sample collection. The probability of mortality was lower in patients with elevated IgG-CTF >821 ng/mL [OR 0.49–0.0] and higher in patients with lowered IgG-CTF <75 ng/mL [OR 3.74–9.64]. Although many patients at the time of sample collection had other conditions (hypertension, hyperlipidemia, or elevated uristatin values), only hypertension correlated with increased likelihood of mortality (OR 4.36–5.34). CONCLUSIONS: This study confirms that retrospective analysis of biorepositories coupled with EHRs can provide insight into novel diagnostic markers and the IgG-CTF marker can predict the likelihood of progressing to additional comorbidities or mortality.
- Open Access
- 24 April 2019
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 170 (2) , 296-309
A Novel Open Access Web Portal for Integrating Mechanistic and Toxicogenomic Study Results
Applying toxicogenomics to improving the safety profile of drug candidates and crop protection molecules is most useful when it identifies relevant biological and mechanistic information that highlights risks and informs risk mitigation strategies. Pathway-based approaches, such as gene set enrichment analysis, integrate toxicogenomic data with known biological process and pathways. Network methods help define unknown biological processes and offer data reduction advantages. Integrating the 2 approaches would improve interpretation of toxicogenomic information. Barriers to the routine application of these methods in genome-wide transcriptomic studies include a need for “hands-on” computer programming experience, the selection of 1 or more analysis methods (eg pathway analysis methods), the sensitivity of results to algorithm parameters, and challenges in linking differential gene expression to variation in safety outcomes. To facilitate adoption and reproducibility of gene expression analysis in safety studies, we have developed Collaborative Toxicogeomics, an open-access integrated web portal using the Django web framework. The software, developed with the Python programming language, is modular, extensible and implements “best-practice” methods in computational biology. New study results are compared with over 4000 rodent liver experiments from Drug Matrix and open TG-GATEs. A unique feature of the software is the ability to integrate clinical chemistry and histopathology-derived outcomes with results from gene expression studies, leading to relevant mechanistic conclusions. We describe its application by analyzing the effects of several toxicants on liver gene expression and exemplify application to predicting toxicity study outcomes upon chronic treatment from expression changes in acute-duration studies.
- 24 April 2019
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 170 (2) , 296-309
Open AccessA Novel Open Access Web Portal for Integrating Mechanistic and Toxicogenomic Study Results
Applying toxicogenomics to improving the safety profile of drug candidates and crop protection molecules is most useful when it identifies relevant biological and mechanistic information that highlights risks and informs risk mitigation strategies. Pathway-based approaches, such as gene set enrichment analysis, integrate toxicogenomic data with known biological process and pathways. Network methods help define unknown biological processes and offer data reduction advantages. Integrating the 2 approaches would improve interpretation of toxicogenomic information. Barriers to the routine application of these methods in genome-wide transcriptomic studies include a need for “hands-on” computer programming experience, the selection of 1 or more analysis methods (eg pathway analysis methods), the sensitivity of results to algorithm parameters, and challenges in linking differential gene expression to variation in safety outcomes. To facilitate adoption and reproducibility of gene expression analysis in safety studies, we have developed Collaborative Toxicogeomics, an open-access integrated web portal using the Django web framework. The software, developed with the Python programming language, is modular, extensible and implements “best-practice” methods in computational biology. New study results are compared with over 4000 rodent liver experiments from Drug Matrix and open TG-GATEs. A unique feature of the software is the ability to integrate clinical chemistry and histopathology-derived outcomes with results from gene expression studies, leading to relevant mechanistic conclusions. We describe its application by analyzing the effects of several toxicants on liver gene expression and exemplify application to predicting toxicity study outcomes upon chronic treatment from expression changes in acute-duration studies.
- 7 January 2019
- Published by Springer Nature in Nature Medicine
- Vol. 25 (1) , 57-59
Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
Diagnostic procedures, therapeutic recommendations, and medical risk stratifications are based on dedicated, strictly controlled clinical trials. However, a plethora of real-world medical data exists, whereupon the increase in data volume comes at the expense of completeness, uniformity, and control. Here, a case-by-case comparison shows that the predictive power of our real world data-based model for diabetes-related chronic kidney disease outperforms published algorithms, which were derived from clinical study data.
- 7 January 2019
- Published by Springer Nature in Nature Medicine
- Vol. 25 (1) , 57-59
Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data
Diagnostic procedures, therapeutic recommendations, and medical risk stratifications are based on dedicated, strictly controlled clinical trials. However, a plethora of real-world medical data exists, whereupon the increase in data volume comes at the expense of completeness, uniformity, and control. Here, a case-by-case comparison shows that the predictive power of our real world data-based model for diabetes-related chronic kidney disease outperforms published algorithms, which were derived from clinical study data.
- Open Access
- 15 November 2018
- Published by Springer Nature in Applied Network Science
- Vol. 3 (1) , 1-16
Predicting onset of complications from diabetes: a graph based approach
Diabetes is a significant health concern with more than 30 million Americans living with diabetes. Onset of diabetes increases the risk for various complications, including kidney disease, myocardial infractions, heart failure, stroke, retinopathy, and liver disease. In this paper, we study and predict the onset of these complications using a network-based approach by identifying fast and slow progressors. That is, given a patient’s diagnosis of diabetes, we predict the likelihood of developing one or more of the possible complications, and which patients will develop complications quickly. This combination of "if a complication will be developed” with ”how fast it will be developed” can aid the physician in developing better diabetes management program for a given patient.
- 15 November 2018
- Published by Springer Nature in Applied Network Science
- Vol. 3 (1) , 1-16
Open AccessPredicting onset of complications from diabetes: a graph based approach
Diabetes is a significant health concern with more than 30 million Americans living with diabetes. Onset of diabetes increases the risk for various complications, including kidney disease, myocardial infractions, heart failure, stroke, retinopathy, and liver disease. In this paper, we study and predict the onset of these complications using a network-based approach by identifying fast and slow progressors. That is, given a patient’s diagnosis of diabetes, we predict the likelihood of developing one or more of the possible complications, and which patients will develop complications quickly. This combination of "if a complication will be developed” with ”how fast it will be developed” can aid the physician in developing better diabetes management program for a given patient.
- 1 June 2005
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (12) , 839-846
Kinomics: characterizing the therapeutically validated kinase space
- 1 June 2005
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (12) , 839-846
Kinomics: characterizing the therapeutically validated kinase space
- 1 April 2005
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (7) , 1943-1947
Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases
- 1 April 2005
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (7) , 1943-1947
Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases
- 1 September 2004
- Published by World Scientific Pub Co Pte Ltd in Journal of Theoretical and Computational Chemistry
- Vol. 03 (03) , 305-323
AB INITIO MO CALCULATION STUDIES FOR SEVERAL NOVEL ENTRIES TO TROPANE COMPOUNDS
Tropane alkaloids are generally known as anticholinergics. Radiolabeled tropane compounds could be brain imaging agents used in biomedical imaging technique positron emission tomography (PET). A novel entry to aryltropane analogs of cocaine was developed based on the conjugate addition reaction of Grignard reagents phenylmagnesium (10), (4'-isopropenylphenyl)magnesium (11), or 2-naphthylmagnesium bromide (12) to α,β-unsaturated esters anhydroecgonine methyl ester (9) or t-butyl ester (13) which gave several aryltropanes (1–8) with high binding affinities for dopamine and serotonin transporters. Basic conditions are frequently employed in the radiolabeling chemistry of many aryltropane cocaine analogs (1–8b, 14–24b). However, isomerization at C-2 position can also occur under basic conditions, resulting in loss of the biologically potent 2β-isomers (1–8b, 14–24b) by conversion to the much less active 2α-isomer (1–8a, 14–24a). Tropinone (25) could be envisaged as a convenient starting material for the synthesis of diverse tropane alkaloids. A novel entry into tropane alkaloid intermediates was developed based on the ring-opening reaction of tropinone. In this reaction, the enolate of tropinone, resulting from deprotonation with lithium diisopropylamide [ LDA , LiN ( CHMe 2)2] or sodium bis(trimethylsilyl)amide [ NaN ( SiMe 3)2] was treated with alkyl chloroformate to give a novel, structurally unique class of tropane alkaloid intermediates 6-N-carboalkyoxy-N-methyl-2-cycloheptenone (26), 1-alkyoxycarboxy-6-N-carboalkoxy-N-methyl-2,7-cyclohept-dien (27) and 6-N-carboalkyoxy-N-methyl-7-carboalkoxy-2,7-cyclohept-dien-ol (28). In this paper we study the conjugate addition reaction of Grignard reagents to α,β-unsaturated esters, the isomerization of aryltropane cocaine analogs, and the ring-opening reaction of tropinone by ab initio MO calculation at the Hartree–Fock (HF) level. The calculation results solely in terms of energetics indicate that the 2α-isomers (equatorial configurations) of aryltropane cocaine analogs are more stable than their 2β-isomers (axial configurations), at the AM1, STO-3G and 3-21G(*) levels, and the Grignard 1,4- and then 1,2-addition (double addition) products (2, 4, 5 and 7) are likely more stable than the Grignard 1,4-addition (single addition) products (1, 3, 6 and 8), respectively, at the STO-3G and 3-21G(*) levels except at the AM1 level. Therefore the tendency of Grignard addition toward double addition is competitive with single addition, and the isomerization tends to the formation of more stable 2α-isomers. Likewise, the calculation results solely in terms of energetics indicate that the stability of the reaction product forms is 28>27>26, at the AM1, STO-3G and 3-21G(*) levels, and the tendency of alkyl chloroformate addition toward double addition to the products 27 and 28 is competitive with single addition to the products 26. Ab initio MO calculations provide a theoretical rationalization for the chemoselectivity of the conjugate addition reaction and the ring-opening reaction, the most stable configurations of reaction products (1–8, 14–24, 26–28), and the isomerization between 1–8b, 14–24b and 1–8a, 14–24a, and between 27 and 28.
- 1 September 2004
- Published by World Scientific Pub Co Pte Ltd in Journal of Theoretical and Computational Chemistry
- Vol. 03 (03) , 305-323
AB INITIO MO CALCULATION STUDIES FOR SEVERAL NOVEL ENTRIES TO TROPANE COMPOUNDS
Tropane alkaloids are generally known as anticholinergics. Radiolabeled tropane compounds could be brain imaging agents used in biomedical imaging technique positron emission tomography (PET). A novel entry to aryltropane analogs of cocaine was developed based on the conjugate addition reaction of Grignard reagents phenylmagnesium (10), (4'-isopropenylphenyl)magnesium (11), or 2-naphthylmagnesium bromide (12) to α,β-unsaturated esters anhydroecgonine methyl ester (9) or t-butyl ester (13) which gave several aryltropanes (1–8) with high binding affinities for dopamine and serotonin transporters. Basic conditions are frequently employed in the radiolabeling chemistry of many aryltropane cocaine analogs (1–8b, 14–24b). However, isomerization at C-2 position can also occur under basic conditions, resulting in loss of the biologically potent 2β-isomers (1–8b, 14–24b) by conversion to the much less active 2α-isomer (1–8a, 14–24a). Tropinone (25) could be envisaged as a convenient starting material for the synthesis of diverse tropane alkaloids. A novel entry into tropane alkaloid intermediates was developed based on the ring-opening reaction of tropinone. In this reaction, the enolate of tropinone, resulting from deprotonation with lithium diisopropylamide [ LDA , LiN ( CHMe 2)2] or sodium bis(trimethylsilyl)amide [ NaN ( SiMe 3)2] was treated with alkyl chloroformate to give a novel, structurally unique class of tropane alkaloid intermediates 6-N-carboalkyoxy-N-methyl-2-cycloheptenone (26), 1-alkyoxycarboxy-6-N-carboalkoxy-N-methyl-2,7-cyclohept-dien (27) and 6-N-carboalkyoxy-N-methyl-7-carboalkoxy-2,7-cyclohept-dien-ol (28). In this paper we study the conjugate addition reaction of Grignard reagents to α,β-unsaturated esters, the isomerization of aryltropane cocaine analogs, and the ring-opening reaction of tropinone by ab initio MO calculation at the Hartree–Fock (HF) level. The calculation results solely in terms of energetics indicate that the 2α-isomers (equatorial configurations) of aryltropane cocaine analogs are more stable than their 2β-isomers (axial configurations), at the AM1, STO-3G and 3-21G(*) levels, and the Grignard 1,4- and then 1,2-addition (double addition) products (2, 4, 5 and 7) are likely more stable than the Grignard 1,4-addition (single addition) products (1, 3, 6 and 8), respectively, at the STO-3G and 3-21G(*) levels except at the AM1 level. Therefore the tendency of Grignard addition toward double addition is competitive with single addition, and the isomerization tends to the formation of more stable 2α-isomers. Likewise, the calculation results solely in terms of energetics indicate that the stability of the reaction product forms is 28>27>26, at the AM1, STO-3G and 3-21G(*) levels, and the tendency of alkyl chloroformate addition toward double addition to the products 27 and 28 is competitive with single addition to the products 26. Ab initio MO calculations provide a theoretical rationalization for the chemoselectivity of the conjugate addition reaction and the ring-opening reaction, the most stable configurations of reaction products (1–8, 14–24, 26–28), and the isomerization between 1–8b, 14–24b and 1–8a, 14–24a, and between 27 and 28.
- 1 March 2004
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1697 (1-2) , 243-257
Kinomics—structural biology and chemogenomics of kinase inhibitors and targets
- 1 March 2004
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1697 (1-2) , 243-257
Kinomics—structural biology and chemogenomics of kinase inhibitors and targets
- 2 December 2003
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (1) , 45-55
Lessons in Molecular Recognition: The Effects of Ligand and Protein Flexibility on Molecular Docking Accuracy
The key to success for computational tools used in structure-based drug design is the ability to accurately place or “dock” a ligand in the binding pocket of the target of interest. In this report we examine the effect of several factors on docking accuracy, including ligand and protein flexibility. To examine ligand flexibility in an unbiased fashion, a test set of 41 ligand−protein cocomplex X-ray structures were assembled that represent a diversity of size, flexibility, and polarity with respect to the ligands. Four docking algorithms, DOCK, FlexX, GOLD, and CDOCKER, were applied to the test set, and the results were examined in terms of the ability to reproduce X-ray ligand positions within 2.0Å heavy atom root-mean-square deviation. Overall, each method performed well (>50% accuracy) but for all methods it was found that docking accuracy decreased substantially for ligands with eight or more rotatable bonds. Only CDOCKER was able to accurately dock most of those ligands with eight or more rotatable bonds (71% accuracy rate). A second test set of structures was gathered to examine how protein flexibility influences docking accuracy. CDOCKER was applied to X-ray structures of trypsin, thrombin, and HIV-1-protease, using protein structures bound to several ligands and also the unbound (apo) form. Docking experiments of each ligand to one “average” structure and to the apo form were carried out, and the results were compared to docking each ligand back to its originating structure. The results show that docking accuracy falls off dramatically if one uses an average or apo structure. In fact, it is shown that the drop in docking accuracy mirrors the degree to which the protein moves upon ligand binding.
- 2 December 2003
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (1) , 45-55
Lessons in Molecular Recognition: The Effects of Ligand and Protein Flexibility on Molecular Docking Accuracy
The key to success for computational tools used in structure-based drug design is the ability to accurately place or “dock” a ligand in the binding pocket of the target of interest. In this report we examine the effect of several factors on docking accuracy, including ligand and protein flexibility. To examine ligand flexibility in an unbiased fashion, a test set of 41 ligand−protein cocomplex X-ray structures were assembled that represent a diversity of size, flexibility, and polarity with respect to the ligands. Four docking algorithms, DOCK, FlexX, GOLD, and CDOCKER, were applied to the test set, and the results were examined in terms of the ability to reproduce X-ray ligand positions within 2.0Å heavy atom root-mean-square deviation. Overall, each method performed well (>50% accuracy) but for all methods it was found that docking accuracy decreased substantially for ligands with eight or more rotatable bonds. Only CDOCKER was able to accurately dock most of those ligands with eight or more rotatable bonds (71% accuracy rate). A second test set of structures was gathered to examine how protein flexibility influences docking accuracy. CDOCKER was applied to X-ray structures of trypsin, thrombin, and HIV-1-protease, using protein structures bound to several ligands and also the unbound (apo) form. Docking experiments of each ligand to one “average” structure and to the apo form were carried out, and the results were compared to docking each ligand back to its originating structure. The results show that docking accuracy falls off dramatically if one uses an average or apo structure. In fact, it is shown that the drop in docking accuracy mirrors the degree to which the protein moves upon ligand binding.